Pfizer to acquire Global Blood Therapeutics for $5.4B August 8, 2022 AutoBot News 0 Pfizer nabbed a $5.4 billion deal to acquire sickle cell drugmaker Global Blood Therapeutics, according to an Aug. 8 press release.
